The money flow into biotechs is very encouraging atm .
NEU, SRX and now PRR all cashed up to progress, and all potentially huge markets .
I think PRR around current market cap and similar cash backing is a prime candidate for further institutional attention .
Still unclear what SRX is looking to acquire and PRR's CVac/Oncology and current market cap fits the possibility .
SRX shareprice has weakened over the last week so potentially something will become clear from them soon .
The money flow into biotechs is very encouraging atm .NEU, SRX...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $551.9M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $1.296M | 3.401M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 54900 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 22008 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |